Lifecome Biochemistry Co.,Ltd. (SHE:002868)
China · Delayed Price · Currency is CNY 37.93
+0.63 (1.69%)
At close: Feb 13, 2026
Lifecome Biochemistry Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -370.47 | -444.86 | -221.82 | -121.94 | -26.04 | 43.21 |
Depreciation & Amortization | 99.83 | 99.83 | 71.06 | 64.17 | 33.94 | 30.45 |
Other Amortization | 1.98 | 1.98 | 0.07 | 0.19 | 0.03 | - |
Loss (Gain) From Sale of Assets | -0.04 | -0.04 | 0.04 | -0 | -0.01 | -0.07 |
Asset Writedown & Restructuring Costs | 171.99 | 171.99 | 24.86 | 6.25 | 0.22 | - |
Loss (Gain) From Sale of Investments | -9.25 | -9.25 | -11.43 | 10.12 | 20.56 | -9.18 |
Provision & Write-off of Bad Debts | 0.38 | 0.38 | 1.27 | 1.35 | 0.72 | -0.95 |
Other Operating Activities | 16.37 | 115.62 | 96.17 | 54.62 | 10.75 | 5.19 |
Change in Accounts Receivable | 47.21 | 47.21 | -51.58 | -3.78 | -17.23 | 44.09 |
Change in Inventory | 53.82 | 53.82 | -97.39 | -73.51 | -15.42 | -5.47 |
Change in Accounts Payable | 56.32 | 56.32 | 15.66 | 61.29 | 34.49 | -18.78 |
Change in Other Net Operating Assets | 30 | 30 | 4.61 | 3.79 | -0.86 | -0.76 |
Operating Cash Flow | 116.56 | 141.41 | -186.76 | -8.83 | 35.17 | 90.72 |
Operating Cash Flow Growth | 142.08% | - | - | - | -61.23% | 22.45% |
Capital Expenditures | -50.07 | -125.06 | -464.54 | -137.32 | -357.17 | -253.79 |
Sale of Property, Plant & Equipment | -63.06 | 0.49 | 4.93 | 0.02 | 4.24 | 3.28 |
Cash Acquisitions | - | - | -90.89 | - | - | - |
Divestitures | - | 27.28 | 294.94 | - | - | - |
Investment in Securities | - | - | - | - | - | 331.67 |
Other Investing Activities | 7.46 | 7.46 | 1.31 | 0.44 | -2.09 | 5.42 |
Investing Cash Flow | -105.67 | -89.82 | -254.25 | -136.86 | -355.01 | 86.58 |
Long-Term Debt Issued | - | 807.58 | 910.8 | 364.79 | 292.89 | 93.8 |
Long-Term Debt Repaid | - | -838.33 | -454.83 | -281.03 | -42.5 | -133.52 |
Net Debt Issued (Repaid) | -105.2 | -30.76 | 455.97 | 83.75 | 250.39 | -39.73 |
Issuance of Common Stock | - | - | 35.7 | - | - | - |
Common Dividends Paid | -51.24 | -48.83 | -24.22 | -12.99 | -26.53 | -23.61 |
Other Financing Activities | 144.62 | - | - | - | - | -31.43 |
Financing Cash Flow | -11.82 | -79.58 | 467.45 | 70.76 | 223.87 | -94.76 |
Foreign Exchange Rate Adjustments | -5.67 | -2.71 | -0.02 | 3.19 | -0.8 | -2.59 |
Net Cash Flow | -6.6 | -30.71 | 26.43 | -71.73 | -96.77 | 79.95 |
Free Cash Flow | 66.48 | 16.35 | -651.3 | -146.15 | -322 | -163.07 |
Free Cash Flow Margin | 11.33% | 2.52% | -128.46% | -44.31% | -88.61% | -52.92% |
Free Cash Flow Per Share | 0.43 | 0.10 | -4.23 | -0.95 | -2.10 | -1.06 |
Cash Income Tax Paid | - | -33.58 | -28.32 | -46.96 | -31.32 | -10.4 |
Levered Free Cash Flow | -63.95 | 21.82 | -231.91 | -464.01 | -258.76 | -151.91 |
Unlevered Free Cash Flow | -26.22 | 60.61 | -208.72 | -453.87 | -257 | -151.3 |
Change in Working Capital | 205.76 | 205.76 | -146.97 | -23.59 | -5 | 22.07 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.